Apolipoprotein A-V is a potent modulator of HDL and VLDL components in preadolescent children

J Atheroscler Thromb. 2009 Apr;16(2):121-6. doi: 10.5551/jat.e356. Epub 2009 Apr 30.

Abstract

Aim: Mice lacking apolipoprotein A-V (apoA-V) displayed an increase in serum triglyceride (TG) levels; however, the correlation of apoA-V levels with TG levels in humans is controversial, and the exact mechanism by which apoA-V affects TG levels is unclear. The aim of the present study was to clarify the impact of apoA-V on the lipoprotein subclass profile in preadolescent children, which has not been studied.

Method: The study subjects were 178 (89 male, 89 female) 4th grade elementary school children (mean+/-SD: 9.5+/-0.5 years old). ApoA-V levels were determined by an enzyme-linked immunosorbent assay, and the lipid component of each lipoprotein fraction and their particle sizes were measured by HPLC.

Results: Levels of apoA-V showed no gender difference in preadolescent children, and were not affected by anthropometric variables. ApoA-V had a negative association with serum TG levels and TG levels in each lipoprotein fraction, and a positive association with HDL-C. In particular, apoA-V appears to contribute to the increase in cholesterol levels in the larger HDL fraction.

Conclusions: It was suggested that apoA-V is a potent modulator of HDL and VLDL components in preadolescent children.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoprotein A-V
  • Apolipoproteins A / blood*
  • Child
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Chromatography, High Pressure Liquid
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Lipid Metabolism*
  • Lipoproteins, HDL / blood*
  • Lipoproteins, VLDL / blood*
  • Male
  • Particle Size
  • Sex Factors
  • Triglycerides / blood

Substances

  • APOA5 protein, human
  • Apolipoprotein A-V
  • Apolipoproteins A
  • Cholesterol, HDL
  • Lipoproteins, HDL
  • Lipoproteins, VLDL
  • Triglycerides
  • Cholesterol